Role of Gastrografin in the Management of Small Bowel Obstruction: A Study of 355 Cases

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The effect of Gastrografin on the management of small bowel obstruction was evaluated retrospectively. A total of 355 patients with small bowel obstruction (excluding those with abdominal wall hernia) formed the study population: 219 (61.7%) were treated conservatively without Gastrografin, and 136 (38.3%) were treated conservatively with Gastrografin. Of the first group, 26.0% required surgery as compared with 9.5% of the second group (p < 0.05). After exclusion of those patients who underwent surgery during the first 24 h because of complete obstruction or progressive deterioration in their condition (15 and 3, respectively), surgical treatment was needed in 19% of those who were treated without Gastrografin versus only 7.3% in those who received Gastrografin (p < 0.05). The use of Gastrografin may reduce the need for surgery in patients with small bowel obstruction, without increasing complication rates.

Related collections

Author and article information

Journal

Journal ID (publisher-id): DSU

Journal ID (nlm-ta): Dig Surg

Journal ID (doi): 10.1159/issn.0253-4886

Title: Digestive Surgery

Publisher: S. Karger AG

ISSN (Print): 0253-4886

ISSN (Electronic): 1421-9883

Publication date Subscription-year: 1996

Publication date (Print): 1996

Publication date (Electronic): 06 November 2008

Volume: 13

Issue: 3

Pages: 201-204

Affiliations

Department of Surgery B, Beilinson Medical Center, Petah Tiqva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Article

Publisher ID: 172429 Other ID: Dig Surg 1996;13:201–204

DOI: 10.1159/000172429

SO-VID: db47ebd3-005c-4e9f-b118-8e758b73cce0

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

History

Date received : 31 May 1995

Date accepted : 12 December 1995

Page count

Pages: 4

Comments

Comment on this article

scite_

Call for Papers: Artificial Intelligence in Gastroenterology

Submit here before September 30, 2024